Full name
GENESIS APTEKI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
58 - Publishing activities
63 - Services related to computing infrastructure, data processing, website management (hosting), and other information services
68 - Real estate activities
73 - Advertising, market research and public relations
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 2,9 | 40,7 | ||
Gross profit (loss) | 3,6 | 2,4 | -3,1 | -230,7 |
EBITDA | 3,6 | 2,4 | -0,4 | -115,4 |
Short time liabilities | 4,6 | 6,1 | 17,9 | 193,5 |
Other operating costs | 0 | -18,1 | ||
Equity capital | 1,9 | 1,2 | -1,5 | -227 |
Operating profit (EBIT) | 3,6 | 2,3 | -0,5 | -121,9 |
Assets | 6,9 | 7,6 | 47,6 | 525 |
Net profit (loss) | 3,6 | 2,4 | -2,8 | -217,2 |
Cash | 0,4 | 0,4 | 3,7 | 860,2 |
Liabilities and provisions for liabilities | 5 | 6,4 | 49,2 | 667,4 |
Net income from sale | 47,8 | 57,9 | 66,4 | 14,8 |
Working assets | 5,8 | 7 | 13 | 84,6 |
Other income costs | 0,7 | 135,5 | ||
Depreciation | 0 | 0 | 0,1 | 451,9 |
% | % | % | p.p. | |
Profitability of capital | 193,1 | 193,7 | 178,8 | -14,9 |
Equity capital to total assets | 27 | 15,9 | -3,2 | -19,1 |
Gross profit margin | 7,5 | 4,1 | -4,6 | -8,7 |
EBITDA Margin | 7,5 | 4,1 | -0,5 | -4,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 39 | 99 | 60 |
Current financial liquidity indicator | 1.2708791494369507 | 1.095475435256958 | 0.721468448638916 | -0,4 |
Net dept to EBITDA | 0.05113707855343819 | -0.0700906440615654 | -77.08589935302734 | -77 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane